Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This guide lives in the PlexusDx Education Hub, where we unpack GLP-1 science, weight-management protocols, and the genetic factors behind metabolic decisions. Open the Education Hub
Start the Microdose GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider reviews your fit.
Start your intake →
Microdosing, defined in plain terms
A "microdose" GLP-1 is simply a compounded formulation that delivers a smaller amount of the active ingredient than the standard titration schedule printed on an FDA-approved brand label. It is not a separate drug and not a shortcut. Compounded GLP-1 refers to a preparation of the active ingredient made by a licensed 503A compounding pharmacy, which is legally and factually distinct from an FDA-approved brand product. Microdosing usually comes up for patients who ran into strong gastrointestinal side effects at label-directed doses and want a gentler on-ramp under provider supervision.
This article walks through the legal basis for compounded microdose formulas, how the 2024 to 2025 FDA shortage resolutions reshaped access, the real differences between a compounded product and a brand pen, and where genetics fit before any of it. Browse the Education Hub for the wider picture.
The legal basis: what a 503A pharmacy may prepare
State-licensed 503A pharmacies fill patient-specific prescriptions written by a valid prescriber. Federal rules let them compound in three broad situations, and a microdose typically lives in the third.
The three compounding categories
They may prepare (1) products that are not commercially available, (2) products currently on the FDA drug shortage list, and (3) patient-specific formulations, meaning a different strength, combination, or vehicle that is medically necessary for one individual. State pharmacy boards and the FDA both keep oversight of this activity, and a lower "microdose" strength is a patient-specific choice made by the prescriber.
What the 2024 to 2025 shortage resolutions changed
The FDA declared semaglutide in shortage in 2022 and tirzepatide in shortage in 2022. While those declarations stood, 503A pharmacies could compound the molecules under the shortage-list pathway. The agency resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025. That narrowed the legitimate compounding window, but it did not close it. Compounded semaglutide and tirzepatide remain available through the patient-specific and not-commercially-available pathways where a clinician can justify them, which is where many microdose formulations sit today.
How a microdose differs from a brand pen
Compounded products are not "generics" in any regulatory sense. They do not go through the same FDA manufacturing review as a brand product, they follow the pharmacy's own quality processes, and they may use different vehicles, strengths, or combinations. Because quality varies pharmacy to pharmacy, it is worth confirming state licensure and, when you can, third-party testing before you fill anything.
Why some microdose formulas include B12
A common compounded variation pairs semaglutide with cyanocobalamin, or vitamin B12. For some patients the B12 can ease injection-site irritation, and it may support energy and neurological health in people who are genuinely B12-deficient. It is a patient-specific formulation decision made by the prescribing provider, not a universal ingredient, and it is not what makes something a "microdose."
The baseline underneath any dose: your genetics
Before deciding whether a lower starting strength makes sense, it helps to understand the biology it acts on. Variants in genes such as FTO, GLP1R, MC4R, and TCF7L2 influence appetite regulation, satiety signaling, and energy balance. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across these systems. It does not predict how you will respond to any medication or dose; it maps pathway-level context you can bring to your provider. PlexusDx offers a Microdose GLP-1 Protocol among its Weight Management Protocols.
Choosing a compounded microdose safely
Confirm the compounding pharmacy is licensed in your state and that a prescriber performs a real clinical evaluation and reviews contraindications first. Treat vendors that ship without a prescription, accept only cryptocurrency, or advertise "research chemical" products as warning signs. A legitimate compounded preparation carries patient-specific labeling, lot numbers, beyond-use dates, and storage instructions consistent with USP standards for nonsterile or sterile compounding.
Frequently Asked Questions
Is a GLP-1 microdose a different medication?
No. A microdose uses the same active ingredient found in standard GLP-1 formulations, simply prepared at a lower strength by a licensed 503A compounding pharmacy under a prescriber order. It is a patient-specific formulation choice, not a distinct drug, and it still requires clinical evaluation and provider oversight before use.
Why would someone start with a microdose?
Microdosing generally appeals to patients who experienced significant gastrointestinal side effects, such as nausea, at label-directed doses. A lower starting amount, chosen by a prescriber, can be part of a gentler approach. Individual experiences vary widely, so this is a conversation to have with a qualified healthcare provider rather than a self-directed plan.
Are compounded microdoses FDA-approved?
Compounded products, including microdose formulations, are not FDA-approved and are not the same as brand products. They are prepared under federal compounding regulations at licensed 503A pharmacies with pharmacy-specific quality controls. Confirm state licensure and, where possible, third-party testing, and be cautious of sellers that skip prescriptions or clinical review entirely.
How does the Precision Peptide Genetic Test fit in?
The test does not predict your response to a compounded microdose or any specific medication. It analyzes pathway-level variants in genes like FTO, MC4R, and TCF7L2 that shape baseline appetite and energy-balance biology, giving you and your provider upstream context that applies before any dose decision is made.
Keep reading across the PlexusDx Education Hub for more evidence-based GLP-1 and metabolic health explainers. Return to the Education Hub
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Is Glutathione: Role in Cellular Health and Biomarker Context
How To Get Mounjaro For Weight Loss: Clinical Pathways and Personalized Evaluation